Common concerns: early gastrointestinal side effects (nausea, vomiting, diarrhea), injection-related issues, cost/insurance barriers, and potential weight regain after stopping
Aronne is the Sanford I
Vitality: This is where the anti-aging claim earns its keep
We believe the results of this study provide further validation of the rapid impact the Allurion Program can have in patients with obesity and other co-morbidities, says Shantanu Gaur, MD, founder and CEO of Allurion, in a release
At the same time, single-cell epigenomic studies suggest that microglia and astrocytes can enter long-lasting, reprogrammed states, retaining aspects of prior immune experience rather than returning to a naive baseline